Related Experiment Video
Updated: May 26, 2026

09:21
Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Gene expression in the Parkinson's disease brain.
Patrick A Lewis1, Mark R Cookson
1Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. patrick.lewis@ucl.ac.uk
Brain Research Bulletin
|December 17, 2011
Summary
Gene expression studies are revolutionizing our understanding of Parkinson's disease. Genome-wide approaches offer new insights into the brain mechanisms driving this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- The sequencing of the human genome has significantly advanced gene expression analysis.
- Genome-wide approaches are increasingly vital for studying human diseases.
- Understanding gene expression in the brain is crucial for neurodegenerative disease research.
Purpose of the Study:
- To review current gene expression studies in Parkinson's disease (PD) brain.
- To explore how advanced techniques provide insights into PD's etiology.
- To highlight the role of genomics in understanding neurodegeneration.
Main Methods:
- Review of current literature on gene expression profiling in Parkinson's disease.
- Analysis of genome-wide association studies (GWAS) and transcriptomic data.
- Examination of bioinformatics tools for gene expression data analysis.
Main Results:
- Gene expression patterns in the Parkinson's disease brain reveal complex molecular alterations.
- Specific pathways and genes are implicated in the pathogenesis of PD.
- Technological advancements enable a more comprehensive understanding of disease mechanisms.
Conclusions:
- Gene expression studies are essential for elucidating the etiology of Parkinson's disease.
- Genome-wide approaches offer powerful tools for identifying disease-associated genes and pathways.
- Further research integrating multi-omics data will accelerate the development of targeted therapies.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
